A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
Trial details
- Registry ID
- NCT06203002
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)NCT06203002 | Lexicon Pharmaceuticals | Phase 2 | Completed | 2025-01-14Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |